Cite
HARVARD Citation
Genoud, V. et al. (n.d.). 115P Therapeutic efficacy of combining the tumour checkpoint controller BAL101553 (lisavanbulin) and immunomodulation in two mouse glioma models with different immunological status. Annals of oncology. p. . [Online].